
π At NEXNEON, we remain committed to advancing Critical Care by offering therapies that provide dependable support in serious and complex clinical situations.
π©Ί We understand the challenges healthcare professionals face when treating severe infections, where precision, reliability, and consistency are essential to achieving stable patient outcomes.Β Our focus is to deliver formulations that are clinically trusted, quality-assured, and suited for real-world hospital needs, enabling confident treatment decisions at the point of care.
π Aligned with this vision, we are pleased to introduce:
π TECONEX (Teicoplanin for Injection)
π¦ A clinically dependable antimicrobial agent developed to support the management of serious bacterial infections caused by Gram-positive organisms, including those that are deep-seated, persistent, or difficult to treat.Β TECONEX provides steady antibacterial coverage, supporting infection control and patient stabilisation in critical conditions.
π©Ί Supporting Confident Care in Serious Infections
π§« Serious Gram-positive infections can affect the bloodstream, bones, joints, and soft tissues, and may progress rapidly. Such cases require an antimicrobial solution that provides consistent, targeted, and dependable action. TECONEX is designed to help clinicians maintain therapeutic control, reduce infection burden, and support recovery when effective management is essential.
Therapeutic Use of TECONEX
π TECONEX is indicated for the treatment of serious Gram-positive bacterial infections, including:
π©Έ Bloodstream Infections (Bacteremia / Sepsis)
πΉ For systemic infections requiring rapid antimicrobial control.
πΉ Helps reduce bacterial load and prevent further systemic complications.
𦴠Bone & Joint Infections
πΉ Effective in osteomyelitis and septic arthritis, where infections are deep-seated and require sustained therapeutic support.
πΉ Provides prolonged antibacterial coverage necessary for slow-penetrating bone tissues.
π§΄ Skin & Soft Tissue Infections
πΉ Useful in treating cellulitis, abscesses, and wound infections, supporting bacterial clearance and healing.
πΉ Helps control local inflammation and promotes the recovery of affected tissue layers.
π§ͺ Composition
π Teicoplanin for Injection (400 mg)
βοΈ Supplied as a lyophilised (freeze-dried) cake
π Packaged in a single-use vial
π§ Suitable for Intramuscular (I.M.) or Intravenous (I.V.) administration
π Key Advantages of TECONEX Injection
π¦ Targeted Protection Against Gram-Positive Pathogens
πΉ Effective against a broad range of Gram-positive bacteria, including resistant strains, supporting precise antimicrobial therapy.
π Clinical Flexibility in Administration
πΉ Can be administered via Intramuscular (I.M.) or Intravenous (I.V.) routes, allowing treatment to be tailored to patient needs and clinical circumstances.
π©Έ Suitable for Deep-Seated and Severe Infections
πΉ Supports management of infections affecting the bone, joint, bloodstream, and soft tissues, where sustained antibacterial coverage is essential.
βοΈ Consistent Therapeutic Levels for Reliable Outcomes
πΉ Helps maintain stable serum concentrations, ensuring dependable and continuous infection control throughout treatment.
βοΈ Stable and Convenient Lyophilised Form
πΉ Ensures longer shelf life, easy storage, and efficient reconstitution for hospital and ward-level use.
π Conclusion
π With the launch of TECONEX, NEXNEON strengthens its commitment to providing trusted, efficient, and clinically reliable solutions for serious Gram-positive infections. TECONEX supports healthcare professionals in delivering clear, confident, and consistent infection management where effective therapy is crucial.
Contact Us Today
π Website: www.nexneon.com
π§ Email: info@nexneon.com
π Phone: +91-9592087889 / +91-9779297885
β¨ You May Also Like :Β NEXNEON CRITICAL CARE : Growing Your Pharma Business Through PCD Franchise Opportunities